Rice Hall James & Associates’s BioSpecifics Technologies Corp. BSTC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-369,359
| Closed | -$19.5M | – | 308 |
|
|
2020
Q3 | $19.5M | Buy |
369,359
+56,634
| +18% | +$3.5M | 0.79% | 42 |
|
|
2020
Q2 | $19.2M | Sell |
312,725
-9,269
| -3% | -$536K | 0.82% | 37 |
|
|
2020
Q1 | $18.2M | Sell |
321,994
-26,468
| -8% | -$1.51M | 1.02% | 29 |
|
|
2019
Q4 | $19.8M | Sell |
348,462
-1,806
| -0.5% | -$95.7K | 0.67% | 49 |
|
|
2019
Q3 | $18.7M | Sell |
350,268
-4,187
| -1% | -$244K | 0.67% | 53 |
|
|
2019
Q2 | $21.2M | Buy |
354,455
+38,483
| +12% | +$2.42M | 0.7% | 43 |
|
|
2019
Q1 | $19.7M | Buy |
315,972
+64,691
| +26% | +$4.28M | 0.63% | 48 |
|
|
2018
Q4 | $15.2M | Buy |
251,281
+69,591
| +38% | +$4.16M | 0.56% | 68 |
|
|
2018
Q3 | $10.6M | Sell |
181,690
-22,493
| -11% | -$1.15M | 0.38% | 95 |
|
|
2018
Q2 | $9.16M | Buy |
204,183
+42,429
| +26% | +$1.82M | 0.33% | 101 |
|
|
2018
Q1 | $7.17M | Buy |
161,754
+6,436
| +4% | +$270K | 0.28% | 102 |
|
|
2017
Q4 | $6.73M | Sell |
155,318
-849
| -0.5% | -$38.2K | 0.26% | 103 |
|
|
2017
Q3 | $7.26M | Sell |
156,167
-5,504
| -3% | -$264K | 0.32% | 93 |
|
|
2017
Q2 | $8M | Buy |
161,671
+31,175
| +24% | +$1.63M | 0.35% | 93 |
|
|
2017
Q1 | $7.15M | Sell |
130,496
-1,519
| -1% | -$80.4K | 0.35% | 94 |
|
|
2016
Q4 | $7.35M | Sell |
132,015
-2,575
| -2% | -$124K | 0.37% | 90 |
|
|
2016
Q3 | $6.15M | Buy |
134,590
+13,588
| +11% | +$546K | 0.32% | 94 |
|
|
2016
Q2 | $4.83M | Buy |
121,002
+7,755
| +7% | +$284K | 0.28% | 91 |
|
|
2016
Q1 | $3.94M | Buy |
113,247
+34,915
| +45% | +$1.28M | 0.23% | 98 |
|
|
2015
Q4 | $3.37M | Buy |
78,332
+27,329
| +54% | +$1.37M | 0.19% | 112 |
|
|
2015
Q3 | $2.22M | Sell |
51,003
-470
| -0.9% | -$25.4K | 0.14% | 154 |
|
|
2015
Q2 | $2.66M | Sell |
51,473
-7,150
| -12% | -$305K | 0.15% | 146 |
|
|
2015
Q1 | $2.29M | Buy |
58,623
+39,003
| +199% | +$1.53M | 0.13% | 178 |
|
|
2014
Q4 | $758K | Sell |
19,620
-2,606
| -12% | -$99.4K | 0.05% | 252 |
|
|
2014
Q3 | $785K | Sell |
22,226
-5,548
| -20% | -$163K | 0.05% | 240 |
|
|
2014
Q2 | $749K | Buy |
27,774
+5,175
| +23% | +$135K | 0.05% | 245 |
|
|
2014
Q1 | $586K | Buy |
22,599
+894
| +4% | +$21.4K | 0.04% | 253 |
|
|
2013
Q4 | $470K | Buy |
+21,705
| New | +$444K | 0.03% | 258 |
|
Other funds holding BSTC
Rice Hall James & Associates's BSTC Position: Q4 2020 in Review
Rice Hall James & Associates sold out of BioSpecifics Technologies Corp. (BSTC) in Q4 2020, closing a stake of 369,359 shares — an estimated $19.5M sold.
Rice Hall James & Associates first reported a position in BSTC in Q4 2013 and held it in 28 quarters. The position peaked at $21.2M in Q2 2019. 1 fund tracked by Wall St. Rank holds BSTC as of Q4 2020.
- Rice Hall James & Associates reported no remaining BioSpecifics Technologies Corp. position as of Q4 2020 after selling out during the quarter.
- Rice Hall James & Associates sold 369,359 BioSpecifics Technologies Corp. shares in Q4 2020, an estimated $19.5M.
- Rice Hall James & Associates first reported a position in BioSpecifics Technologies Corp. in Q4 2013 and held it in 28 quarters.
- Rice Hall James & Associates's BioSpecifics Technologies Corp. position peaked at $21.2M in Q2 2019.
- 1 fund tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q4 2020.
Based on Rice Hall James & Associates's 13F filing for Q4 2020, filed 16 Feb 2021.